The discovery of rofecoxib, [MK 966, Vioxx, 4-(4′-methylsulfonylphenyl) 3-phenyl-2(5H)-furanone], an orally active cyclooxygenase -2-inhibitor - Prasit, P; Wang, Z; Brideau, C (Bioorg Med Chem Lett, 1999)
et al.